1760 On Other Exchanges
Symbol
Exchange
Taiwan

panion & bf biotech inc (1760) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for PANION & BF BIOTECH INC (1760)
\

Related News

No related news articles were found.

panion & bf biotech inc (1760) Related Businessweek News

No Related Businessweek News Found

panion & bf biotech inc (1760) Details

Panion & Bf Biotech Inc., a pharmaceutical company, develops, manufactures, and sells various pharmaceutical products in Taiwan. The company offers products in the therapeutic areas of kidney, respiratory tract, gastrointestinal tract, medical beauty, and scalp hair root. It also provides oral drugs, external preparations, and disease prevention products, as well as pet care products, including surgical and skin prescriptions. In addition, the company researches and develops western medicine, infection control products, test and diagnosis products, and cosmetic maintenance products, as well as generic drugs, medical products, nutrition and health care products, functional food, cleaning and disinfecting products, etc. Panion & Bf Biotech Inc. was founded in 1976 and is headquartered in Taipei City, Taiwan.

Founded in 1976

panion & bf biotech inc (1760) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

panion & bf biotech inc
Panion & Bf Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019

Panion & Bf Biotech Inc. announced earnings results for the first quarter ended March 31, 2019. For the first quarter, the company announced sales was TWD 356.902 million compared to TWD 262.755 million a year ago. Operating income was TWD 51.471 million compared to TWD 15.179 million a year ago. Net income was TWD 39.636 million compared to TWD 5.270 million a year ago. Basic earnings per share was TWD 0.52 compared to TWD 0.07 a year ago.

Panion & Bf Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2018

Panion & Bf Biotech Inc. announced earnings results for the full year ended December 31, 2018. For the full year, the company announced sales was TWD 1,408.741 million compared to TWD 1,212.478 million a year ago. Operating income was TWD 212.538 million compared to TWD 144.723 million a year ago. Net income was TWD 159.171 million compared to TWD 90.539 million a year ago. Basic earnings per share was TWD 2.09 compared to TWD 1.33 a year ago. Diluted earnings per share was TWD 2.08 compared to TWD 1.33 a year ago.

Panion & Bf Biotech Inc., Annual General Meeting, Jun 06, 2019

Panion & Bf Biotech Inc., Annual General Meeting, Jun 06, 2019.

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

1760 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 1760.
View Industry Companies
 

Industry Analysis

1760

Industry Average

Valuation 1760 Industry Range
Price/Earnings 34.8x
Price/Sales 4.5x
Price/Book 4.8x
Price/Cash Flow 34.8x
TEV/Sales 4.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact PANION & BF BIOTECH INC, please visit www.pbf.com.tw. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.